Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early carvedilol and enalapril for mild cardiotoxicity during anthracycline and/or trastuzumab treatment in operable breast cancer
2011-002207-15Phase 2Active
- Sponsor
- Fondazione del Piemonte per l'Oncologia
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carvedilol and enalapril in Cardiotoxicity and left ventricular dysfunction, sponsored by Fondazione del Piemonte per l'Oncologia. Started Mar 2012; status: active.
02
Drugs
carvedilolenalapril
03
Conditions
Cardiotoxicityleft ventricular dysfunction
Beyond the preview
Go deeper on 2011-002207-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002207-15.